ESC Premium Access

Predictors, feasibility and outcomes of coronary interventions up to 3 years after TAVI with a balloon-expandable valve. Results from a large European multicenter registry.

Congress Session

About the speaker

Associate Professor Giuseppe Tarantini

University Hospital of Padova, Padua (Italy)
9 presentations
1 follower

8 more presentations in this session

Incidence of bicuspid aortic valve in 16,185 neonates by echocardiographic screening in a single institution: is it really congenial?

Speaker: Doctor K. Waki (Kurashiki, JP)


Predictors of access site complication in transfemoral transcatheter aortic valve implantation

Speaker: Mr M. Potratz (Bad Oeynhausen, DE)


Clinical outcomes after early vs new generation TAVR device deployment

Speaker: Doctor L. Kalinczuk (Warsaw, PL)


Differences in short-term outcome between balloon- and self-expandable TAVR devices relating to more than one generation.

Speaker: Assistant Professor V. Veulemans (Duesseldorf, DE)


Incidence and outcomes of delirium in patients undergoing transcatheter aortic valve replacement.

Speaker: Doctor T. Luque Diaz (Madrid, ES)


Access the full session

Poster Session 4 - Structural percutaneous intervention

Speakers: Associate Professor G. Tarantini, Doctor K. Waki, Mr M. Potratz, Doctor L. Kalinczuk, Assistant Professor V. Veulemans...

About the event



31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk